NCT07784959
- Conditions
- ALK Positive, ALK Positive Non-small Cell Lung Cancer, ALK+ Non-Small-Cell Lung Carcinoma, +1 more
- Locations
-
- NEXT Virginia Fairfax, Virginia, United States
Clinical trial condition
ALK Positive
Explore clinical trials studying ALK Positive. Study availability and eligibility vary by location and protocol.
5 public trials
1 recruiting study
ALK Positive trial results
NCT06736561
- Conditions
- ALK Positive, Ensartinib, NSCLC, +1 more
- Locations
-
Not specified
Active, not recruiting
Ceritinib and Everolimus in Treating Patients With Locally Advanced or Metastatic Solid Tumors or Stage IIIB-IV Non-small Cell Lung Cancer
NCT02321501
- Conditions
- ALK Positive, Locally Advanced Malignant Solid Neoplasm, Metastatic Malignant Solid Neoplasm, +8 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
Active, not recruiting
Crizotinib in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Removed by Surgery and ALK Fusion Mutations (An ALCHEMIST Treatment Trial)
NCT02201992
- Conditions
- ALK Gene Rearrangement, ALK Gene Translocation, ALK Positive, +15 more
- Locations
-
- University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
- Southern Cancer Center PC-Daphne Daphne, Alabama, United States
- Southern Cancer Center PC-Mobile Mobile, Alabama, United States
- Southern Cancer Center PC-Providence Mobile, Alabama, United States
NCT02227940
- Conditions
- ALK Positive, Advanced Malignant Solid Neoplasm, Digestive System Diseases, +10 more
- Locations
-
- Roswell Park Cancer Institute Buffalo, New York, United States